Asset Publisher

New skeletal disease found and explained by CMM researchers

New skeletal disease found and explained by CMM researchers

Researchers from the group Rare Diseases have discovered a new and rare skeletal disease. In a study published in the journal Nature Medicine they describe the molecular mechanism of the disease, in which small RNA molecules play a role that has never before been observed in a congenital human disease.

The study’s lead author Giedre Grigelioniene, physician and associate professor, identified the disease causing mutation in a gene called MIR140 together with Fulya Taylan, assistant professor in the same research group. The gene does not give rise to a protein but to a so-called micro-RNA (miR-140), a small RNA molecule that regulates other genes. The identified mutation knocks out a normal function of the micro-RNA, which is replaced by a different function. The mechanism has never before been described involving small RNAs in human congenital disease.

The study was carried out in collaboration with researchers from, among others, Massachusetts General Hospital and Harvard University in Boston and the Massachusetts Institute of Technology.

 

Giedre Grigelioniene and Fulya Taylan. Photo: Rick Guidotti

 

The study Gain-of-function mutation of microRNA-140 in human skeletal dysplasia was published in the scientific journal Nature Medicine on February 25 2019.

Read more about the study at Karolinska Institutet website.

 

NEWS

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million Sweden’s innovation agency Vinnova extends the funding of the national...

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius Professor Marie Wahren-Herlenius, Group Leader at CMM, has received the biggest yearly grant in Sweden...

Simple blood test may help predict MS progression, study finds

Simple blood test may help predict MS progression, study finds Photo: Ali Manouchehrinia   A study led by the CMM researchers Ali Manouchehrinia (first...

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis   Karl Carlström, photo Stefan Zimmerman   Karl...

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows A study made by Philippe Melas from Karolinska Institutet together with colleagues at Columbia...

Grant to Eduardo Villablanca for studies of stem cell-mediated tissue regeneration in the intestine

Grant to Eduardo Villablanca for studies of stem cell-mediated tissue regeneration in the intestine Associate Professor Eduardo Villablanca, Group Leader at CMM, has received a Junior...

Anca Catrina, Wallenberg Clinical Scholar 2020

Anca Catrina, Wallenberg Clinical Scholar 2020 We congratulate our CMM researcher Professor Anca Catrina, Group Leader at Karolinska Institutet and senior physician, who has been appointed...

Junior Investigator Award to Carmen Gerlach

Junior Investigator Award to Carmen Gerlach Assistant Professor Carmen Gerlach, Team Leader at CMM, will receive funding during six years from the Swedish Cancer Society (Cancerfonden) for...

Proteins that protect against joint inflammation identified

Proteins that protect against joint inflammation identified " Endogenous proteins that play a vital part in allergies and parasitic infection can prevent the immune system from wrongly...

New study shows that Proprotein Convertase 6 plays a key role in vascular disease

New study shows that Proprotein Convertase 6 plays a key role in vascular disease In a new study published in Circulation Research, researchers at CMM show that the enzyme PCSK6, the...